Download PDF
Journal of Pediatric Neurology 2018; 16(05): 305-312
DOI: 10.1055/s-0038-1667153
Review Article
Georg Thieme Verlag KG Stuttgart · New York

Phacomatosis Pigmentovascularis

Serena Strano
1   Unit of Rare Diseases of the Nervous System in Childhood, Department of Clinical and Experimental Medicine, Section of Pediatrics and Child Neuropsychiatry, University of Catania, Catania, Italy
,
Andrea D. Praticò
1   Unit of Rare Diseases of the Nervous System in Childhood, Department of Clinical and Experimental Medicine, Section of Pediatrics and Child Neuropsychiatry, University of Catania, Catania, Italy
2   Maurice Wohl Clinical Neuroscience Institute, King's College London, London, United Kingdom
,
Agata Polizzi
3   Institute of Neurological Sciences, National Research Council, Catania, Italy
,
Maria Teresa Garozzo
1   Unit of Rare Diseases of the Nervous System in Childhood, Department of Clinical and Experimental Medicine, Section of Pediatrics and Child Neuropsychiatry, University of Catania, Catania, Italy
,
Concetta Pirrone
4   Section of Psychology, Department of Educational Sciences, University of Catania, Catania, Italy
,
Antonio Zanghì
5   Department of Medical and Surgical Sciences and Advanced Technology “G.F. Ingrassia,” University of Catania, Catania, Italy
,
Carmelo Schepis
6   Unit of Dermatology, Oasi Research Institute - IRCCS, Troina, Enna, Italy
,
Francesco Lacarrubba
7   Dermatology Clinic, University of Catania, Catania, Italy
,
Franco Dinotta
7   Dermatology Clinic, University of Catania, Catania, Italy
,
Stefania Salafia
8   Unit of Pediatrics, Lentini Hospital, Lentini, Italy
,
Martino Ruggieri
1   Unit of Rare Diseases of the Nervous System in Childhood, Department of Clinical and Experimental Medicine, Section of Pediatrics and Child Neuropsychiatry, University of Catania, Catania, Italy
,
Giuseppe Micali
7   Dermatology Clinic, University of Catania, Catania, Italy
› Author Affiliations
Further Information

Publication History

12 February 2018

20 May 2018

Publication Date:
20 August 2018 (online)

Also available at
    Permissions and Reprints

Abstract

The coexistence of a widespread vascular nevus and an extensive pigmentary nevus is defined as “phacomatosis pigmentovascularis” (PPV). More than 250 (sporadic) cases of PPV have been so far reported, mainly in Asian or Asian-related populations: mutations in genes related to angiogenic pathways (RAS, MAPK, mTOR, PI3K/AKT, and GNAQ) have been recently identified as the causes of this complex phenotype. In many cases, mutations in two different genes may coexist, representing the classical example of “twin spotting” phenomenon. PPV is usually associated with several extracutaneous anomalies including ocular manifestations (melanosis bulbi, glaucoma, iris mammillations, megalocornea, buphthalmos, strabismus, and hyperpigmentation of the conjunctiva, sclera, episclera, iris, trabecular meshwork, and choroid) and musculoskeletal alterations (limb hypertrophy, Klippel–Trenaunay type abnormalities, hemifacial hypertrophy, hemicorporal hypertrophy, macrocephaly, microcephaly, and scoliosis). Central nervous system anomalies have been reported in most of the patients and include seizure, cognitive delay, cerebral atrophy, hydrocephalus, sensorineural deafness, and intracranial hypertension, as well as migraine, pseudotumor cerebri, and intracerebral vascular malformations. More rarely, PPV has been associated with structural and/or vascular renal anomalies, hepatosplenomegaly, pyogenic granuloma, cavernous hemangioma, portal hypertension, umbilical hernia, hypoplasia of leg veins, and hypo- or hyperactivity of the immune system.

Keywords

phacomatosis - phakomatosis - pigmentovascularis - muscoloskeletal alterations - central nervous system anomalies - GNAQ - AKT - mTOR - twin spotting
 

  • References

  • 1 Happle R. Phacomatosis pigmentovascularis revisited and reclassified. Arch Dermatol 2005; 141 (03) 385-388
    CrossrefPubMedGoogle Scholar
  • 2 Ruiz-Maldonado R, Tamayo L, Laterza AM, Brawn G, Lopez A. Phacomatosis pigmentovascularis: a new syndrome? Report of four cases. Pediatr Dermatol 1987; 4 (03) 189-196
    CrossrefPubMedGoogle Scholar
  • 3 Vidaurri-de la Cruz H, Tamayo-Sanchez l, Duran-McKinster C, Orozco-Covarrubias Mde L, Ruiz-Maldonado R. Phakomatosis pigmentovascularis II and II B: clinical findings in 24 patients. J Dermatol 2003; 30: 381-388
    CrossrefPubMedGoogle Scholar
  • 4 Happle R. Loss of heterozygosity in human skin. J Am Acad Dermatol 1999; 41 (2 Pt 1): 143-164
    CrossrefPubMedGoogle Scholar
  • 5 Ruggieri M, Polizzi A. From Aldrovandi's “Homuncio” (1592) to Buffon's girl (1749) and the “Wart Man” of Tilesius (1793): antique illustrations of mosaicism in neurofibromatosis?. J Med Genet 2003; 40 (03) 227-232
    CrossrefPubMedGoogle Scholar
  • 6 Ruggieri M, Praticò AD, Caltabiano R, Polizzi A. Rediagnosing one of Smith's patients (John McCann) with “neuromas tumours” (1849). Neurol Sci 2017; 38 (03) 493-499
    CrossrefPubMedGoogle Scholar
  • 7 Ruggieri M, Praticò AD, Scuderi A, Sorge G, Polizzi A. The multiple faces of artwork diagnoses. Lancet Neurol 2017; 16 (06) 417-418
    CrossrefPubMedGoogle Scholar
  • 8 Ruggieri M, Praticò AD, Caltabiano R, Polizzi A. Early history of the different forms of neurofibromatosis from ancient Egypt to the British Empire and beyond: first descriptions, medical curiosities, misconceptions, landmarks, and the persons behind the syndromes. Am J Med Genet A 2018; 176 (03) 515-550
    CrossrefPubMedGoogle Scholar
  • 9 Ruggieri M, Praticò AD, Serra A. , et al. Early history of neurofibromatosis type 2 and related forms: earliest descriptions of acoustic neuromas, medical curiosities, misconceptions, landmarks and the pioneers behind the eponyms. Childs Nerv Syst 2017; 33 (04) 549-560
    CrossrefPubMedGoogle Scholar
  • 10 Brosius S. A history of von Recklinghausen's NF1. J Hist Neurosci 2010; 19 (04) 333-348
    CrossrefPubMedGoogle Scholar
  • 11 Ota N, Kawarnura T, Ito N. Phakomatosis pigmentovascularis. Jpn J Dermatol B 1947; 57: 1-3
    PubMedGoogle Scholar
  • 12 Gomez MR. Neurocutaneous Disorders. A Practical Approach. Boston, MA: Butterworths; 1987
    Google Scholar
  • 13 Papetti L, Tarani L, Nicita F. , et al. Macrocephaly-capillary malformation syndrome: description of a case and review of clinical diagnostic criteria. Brain Dev 2012; 34 (02) 143-147
    CrossrefPubMedGoogle Scholar
  • 14 Ruggieri M, Milone P, Pavone P. , et al. Nevus vascularis mixtus (cutaneous vascular twin nevi) associated with intracranial vascular malformation of the Dyke-Davidoff-Masson type in two patients. Am J Med Genet A 2012; 158A (11) 2870-2880
    CrossrefPubMedGoogle Scholar
  • 15 Ruggieri M, Polizzi A, Strano S. , et al. Mixed vascular nevus syndrome: a report of four new cases and a literature review. Quant Imaging Med Surg 2016; 6 (05) 515-524
    CrossrefPubMedGoogle Scholar
  • 16 Barbagallo M, Ruggieri M, Incorpora G. , et al. Infantile spasms in the setting of Sturge-Weber syndrome. Childs Nerv Syst 2009; 25 (01) 111-118
    CrossrefPubMedGoogle Scholar
  • 17 Ruggieri M, D'Arrigo G, Abbate M, Distefano A, Upadhyaya M. Multiple coronary artery aneurysms in a child with neurofibromatosis type 1. Eur J Pediatr 2000; 159 (07) 477-480
    CrossrefPubMedGoogle Scholar
  • 18 Ruggieri M, Packer RJ. Why do benign astrocytomas become malignant in NF1?. Neurology 2001; 56 (07) 827-829
    CrossrefPubMedGoogle Scholar
  • 19 Ruggieri M, Polizzi A. Choroidal abnormalities and mental retardation in neurofibromatosis type 1. Lancet 2001; 357 (9252): 311-312
    PubMedGoogle Scholar
  • 20 Ruggieri M, Pavone V, Tiné A. , et al. Ossifying fibroma of the skull in a patient with neurofibromatosis type 1. Case report. J Neurosurg 1996; 85 (05) 941-944
    CrossrefPubMedGoogle Scholar
  • 21 Fernández-Guarino M, Boixeda P, de Las Heras E, Aboin S, García-Millán C, Olasolo PJ. Phakomatosis pigmentovascularis: clinical findings in 15 patients and review of the literature. J Am Acad Dermatol 2008; 58 (01) 88-93
    CrossrefPubMedGoogle Scholar
  • 22 Hasegawa Y, Yasuhara M. Phakomatosis pigmentovascularis type IVa. Arch Dermatol 1985; 121 (05) 651-655
    CrossrefPubMedGoogle Scholar
  • 23 Enjolras O, Mulliken JB. Vascular malformations. In: Harper J, Oranje A, Prose N. , eds. Textbook of Dermatology. Oxford: Blackwell Science; 2000: 975-976
    Google Scholar
  • 24 Bleehen SS. Disorders of skin colour. In: Champion RH, Burton JL, Burns DA, Breathnach SM. , eds. Rook/Wilkinson/Ebling Textbook of Dermatology. 6th ed. Oxford: Blackwell Science; 1998: 1791-1792
    Google Scholar
  • 25 Al Robaee A, Banka N, Alfadley A. Phakomatosis pigmentovascularis type IIb associated with Sturge-Weber syndrome. Pediatr Dermatol 2004; 21 (06) 642-645
    CrossrefPubMedGoogle Scholar
  • 26 Ajith C, Narang T, Kanwar AJ. Phakomatosis pigmentovascularis type II b associated with Sturge-Weber syndrome. Clin Exp Dermatol 2006; 31 (04) 590-592
    PubMedGoogle Scholar
  • 27 Kola B, Mehrafza M, Kane A. Phacomatosis pigmentovascularis: simple presentation of a not so simple dermatological condition. Clin Pediatr (Phila) 2017; DOI: 10.1177/0009922817737088.
    CrossrefPubMedGoogle Scholar
  • 28 Castori M, Scarciolla O, Morlino S. , et al. Whorled hairless nevus of the scalp, linear hyperpigmentation, and telangiectatic nevi of the lower limbs: a novel variant of the “phacomatosis complex”. Am J Med Genet A 2012; 158A (02) 445-449
    CrossrefPubMedGoogle Scholar
  • 29 Chang BP, Hsu CH, Chen HC, Hsieh JW. An infant with extensive Mongolian spot, naevus flammeus and cutis marmorata telangiectatica congenita: a unique case of phakomatosis pigmentovascularis. Br J Dermatol 2007; 156 (05) 1068-1071
    CrossrefPubMedGoogle Scholar
  • 30 Chhajed M, Pandit S, Dhawan N, Jain A. Klippel-Trenaunay and Sturge-Weber overlap syndrome with phakomatosis pigmentovascularis. J Pediatr Neurosci 2010; 5 (02) 138-140
    CrossrefPubMedGoogle Scholar
  • 31 Cho S, Choi JH, Sung KJ, Moon KC, Koh JK. Phakomatosis pigmentovascularis type IIB with neurologic abnormalities. Pediatr Dermatol 2001; 18 (03) 263
    PubMedGoogle Scholar
  • 32 Dippel E, Utikal J, Feller G. , et al. Nevi flammei affecting two contralateral quadrants and nevus depigmentosus: a new type of phacomatosis pigmentovascularis?. Am J Med Genet A 2003; 119A (02) 228-230
    CrossrefPubMedGoogle Scholar
  • 33 Du LC, Delaporte E, Catteau B, Destee A, Piette F. Phacomatosis pigmentovascularis type II. Eur J Dermatol 1998; 8 (08) 569-572
    PubMedGoogle Scholar
  • 34 Finklea LB, Mohr MR, Warthan MM, Darrow DH, Williams JV. Two reports of phacomatosis pigmentovascularis type IIb, one in association with Sturge-Weber syndrome and Klippel-Trenaunay syndrome. Pediatr Dermatol 2010; 27 (03) 303-305
    CrossrefPubMedGoogle Scholar
  • 35 Guiglia MC, Prendiville JS. Multiple granular cell tumors associated with giant speckled lentiginous nevus and nevus flammeus in a child. J Am Acad Dermatol 1991; 24 (2 Pt 2): 359-363
    CrossrefPubMedGoogle Scholar
  • 36 Gupta A, Dubey S, Agarwal M. A case of Sturge-Weber syndrome in association with phacomatosis pigmentovascularis and developmental glaucoma. J AAPOS 2007; 11 (04) 398-399
    CrossrefPubMedGoogle Scholar
  • 37 Hall BD, Cadle RG, Morrill-Cornelius SM, Bay CA. Phakomatosis pigmentovascularis: implications for severity with special reference to Mongolian spots associated with Sturge-Weber and Klippel-Trenaunay syndromes. Am J Med Genet A 2007; 143A (24) 3047-3053
    CrossrefPubMedGoogle Scholar
  • 38 Happle R, Steijlen PM. Phacomatosis pigmentovascularis gedeutet als ein Phänomen der Zwillingsflecken. Hautarzt 1989; 40 (11) 721-724
    PubMedGoogle Scholar
  • 39 Jeon SY, Ha SM, Ko DY, Hong JW, Song KH, Kim KH. Phakomatosis pigmentovascularis Ib with left-sided hemihypertrophy, interdigital gaps and scoliosis: a unique case of phakomatosis pigmentovascularis. J Dermatol 2013; 40 (01) 78-79
    CrossrefPubMedGoogle Scholar
  • 40 Kanaheswari Y, Hamzaini AH, Wong SW, Zulfiqar A. Malignant hypertension in a child with phakomatosis pigmentovascularis type II b. Acta Paediatr 2008; 97 (11) 1589-1591
    CrossrefPubMedGoogle Scholar
  • 41 Kikuchi I, Okazaki M. Congenital temporal alopecia in phakomatosis pigmentovascularis. J Dermatol 1982; 9 (06) 485-487
    CrossrefPubMedGoogle Scholar
  • 42 Kiley MA, Oxbury JM, Coley SC. Intracranial hypertension in Sturge-Weber/Klippel-Trenaunay-Weber overlap syndrome due to impairment of cerebral venous outflow. J Clin Neurosci 2002; 9 (03) 330-333
    CrossrefPubMedGoogle Scholar
  • 43 Kim HJ, Park KB, Yang JM, Park SH, Lee ES. Congenital triangular alopecia in phakomatosis pigmentovascularis: report of 3 cases. Acta Derm Venereol 2000; 80 (03) 215-216
    CrossrefPubMedGoogle Scholar
  • 44 Kim YC, Park HJ, Cinn YW. Phakomatosis pigmentovascularis type IIa with generalized vitiligo. Br J Dermatol 2002; 147 (05) 1028-1029
    CrossrefPubMedGoogle Scholar
  • 45 Lo PY, Tzung TY. Phakomatosis pigmentovascularis type IIb with a patent umbilical vein and inferior vena cava hypoplasia. Br J Dermatol 2003; 148 (04) 836-838
    CrossrefPubMedGoogle Scholar
  • 46 Ma H, Liao M, Qiu S, Luo R, Lu R, Lu C. The case of a boy with nevus of Ota, extensive Mongolian spot, nevus flammeus, nevus anemicus and cutis marmorata telangiectatica congenita: a unique instance of phacomatosis pigmentovascularis. An Bras Dermatol 2015; 90 (03) (Suppl. 01) 10-12
    CrossrefPubMedGoogle Scholar
  • 47 Namiki T, Takahashi M, Nojima K. , et al. Phakomatosis pigmentovascularis type IIb: a case with Klippel-Trenáunay syndrome and extensive dermal melanocytosis as nevus of Ota, nevus of Ito and ectopic Mongolian spots. J Dermatol 2017; 44 (03) e32-e33
    CrossrefPubMedGoogle Scholar
  • 48 Woo SH, Kwak HB, Park SK, Yun SK, Kim HU, Park J. An unusual case of phakomatosis pigmentovascularis type IIb with Becker's nevus. Eur J Dermatol 2017; 27 (01) 83-85
    PubMedGoogle Scholar
  • 49 Patil B, Sinha G, Nayak B, Sharma R, Kumari S, Dada T. Bilateral Sturge–Weber and phakomatosis pigmentovascularis with glaucoma, an overlap syndorme. Case Rep Ophthalmol Med 2015; 2015: 106932
    PubMedGoogle Scholar
  • 50 Purkait R, Samanta T, Sinhamahapatra T, Chatterjee M. Overlap of Sturge-Weber syndrome and Klippel-Trenaunay syndrome. Indian J Dermatol 2011; 56 (06) 755-757
    CrossrefPubMedGoogle Scholar
  • 51 Sen S, Bala S, Halder C, Ahar R, Gangopadhyay A. Phakomatosis pigmentovascularis presenting with Sturge-Weber syndrome and Klippel-Trenaunay syndrome. Indian J Dermatol 2015; 60 (01) 77-79
    CrossrefPubMedGoogle Scholar
  • 52 Torrelo A, Zambrano A, Happle R. Cutis marmorata telangiectatica congenita and extensive mongolian spots: type 5 phacomatosis pigmentovascularis. Br J Dermatol 2003; 148 (02) 342-345
    CrossrefPubMedGoogle Scholar
  • 53 Tsuruta D, Fukai K, Seto M. , et al. Phakomatosis pigmentovascularis type IIIb associated with Moyamoya disease. Pediatr Dermatol 1999; 16 (01) 35-38
    CrossrefPubMedGoogle Scholar
  • 54 Yang Y, Guo X, Xu J, Ye Y, Liu X, Yu M. Phakomatosis pigmentovascularis associated with Sturge–Weber Syndrome, Ota Nevus, and congenital glaucoma. Medicine (Baltimore) 2015; 94 (26) e1025
    PubMedGoogle Scholar
  • 55 Unger R, Alsufyani MA. Bilateral temporal triangular alopecia associated with phakomatosis pigmentovascularis type iv successfully treated with follicular unit transplantation. Case Rep Dermatol Med 2011; 2011: 129541
    PubMedGoogle Scholar
  • 56 Ruggieri M, Rizzo R, Pavone P, Babeli S, Sorge G, Happle R. Temporal triangular alopecia in a mother and her daughter associated with mental retardation and seizures. Arch Dermatol 2000; 136: 426-427
    CrossrefPubMedGoogle Scholar
  • 57 Spalice A, Ruggieri M, Grosso S. , et al. Dysembryoplastic neuroepithelial tumors: a prospective clinicopathologic and outcome study of 13 children. Pediatr Neurol 2010; 43 (06) 395-402
    CrossrefPubMedGoogle Scholar
  • 58 Kono T, Erçöçen AR, Chan HH. , et al. Treatment of phacomatosis pigmentovascularis: a combined multiple laser approach. Dermatol Surg 2003; 29 (06) 642-646
    PubMedGoogle Scholar
  • 59 Shields CL, Kligman BE, Suriano M. , et al. Phacomatosis pigmentovascularis of cesioflammea type in 7 patients: combination of ocular pigmentation (melanocytosis or melanosis) and nevus flammeus with risk for melanoma. Arch Ophthalmol 2011; 129 (06) 746-750
    CrossrefPubMedGoogle Scholar
  • 60 Abdolrahimzadeh S, Scavella V, Felli L, Cruciani F, Contestabile MT, Recupero SM. Ophthalmic alterations in the Sturge-Weber syndrome, Klippel-Trenaunay syndrome, and the phakomatosis pigmentovascularis: an independent group of conditions?. BioMed Res Int 2015; 2015: 786519
    PubMedGoogle Scholar
  • 61 Nanda A, Al-Abdulrazzaq HK, Habeeb YK. , et al. Phacomatosis pigmentovascularis: report of four new cases. Indian J Dermatol Venereol Leprol 2016; 82 (03) 298-303
    CrossrefPubMedGoogle Scholar
  • 62 Ruggieri M, Pavone P, Polizzi A. , et al. Ophthalmological manifestations in segmental neurofibromatosis type 1. Br J Ophthalmol 2004; 88 (11) 1429-1433
    CrossrefPubMedGoogle Scholar
  • 63 Pavone P, Praticò AD, Rizzo R. , et al. A clinical review on megalencephaly: a large brain as a possible sign of cerebral impairment. Medicine (Baltimore) 2017; 96 (26) e6814
    PubMedGoogle Scholar
  • 64 Pavone P, Falsaperla R, Ruggieri M. , et al. Clinical course of NMDAr encephalitis and effectiveness of cyclosphosphamide treatment. J Pediatr Neurol 2017; 15: 84-89
    Article in Thieme ConnectPubMedGoogle Scholar
  • 65 Pavone P, Nigro F, Falsaperla R. , et al. Hemihydranencephaly: living with half brain dysfunction. Ital J Pediatr 2013; 39: 3
    CrossrefPubMedGoogle Scholar
  • 66 Pavone P, Praticò AD, Vitaliti G. , et al. Hydranencephaly: cerebral spinal fluid instead of cerebral mantles. Ital J Pediatr 2014; 40: 79
    CrossrefPubMedGoogle Scholar
  • 67 Sorge G, Ruggieri M, Polizzi A, Scuderi A, Di Pietro M. SHORT syndrome: a new case with probable autosomal dominant inheritance. Am J Med Genet 1996; 61 (02) 178-181
    CrossrefPubMedGoogle Scholar
  • 68 Ruggieri M, Pavone V, Polizzi A. , et al. Tuberculosis of the ankle in childhood: clinical, roentgenographic and computed tomography findings. Clin Pediatr (Phila) 1997; 36 (09) 529-534
    CrossrefPubMedGoogle Scholar
  • 69 Polizzi A, Pavone P, Ciancio E, La Rosa C, Sorge G, Ruggieri M. Hypertrichosis cubiti (hairy elbow syndrome): a clue to a malformation syndrome. J Pediatr Endocrinol Metab 2005; 18 (10) 1019-1025
    PubMedGoogle Scholar
  • 70 Hagiwara K, Uezato H, Nonaka S. Phacomatosis pigmentovascularis type IIb associated with Sturge-Weber syndrome and pyogenic granuloma. J Dermatol 1998; 25 (11) 721-729
    CrossrefPubMedGoogle Scholar
  • 71 Saricaoğlu MS, Güven D, Karakurt A, Sengun A, Ziraman I. An unusual case of Sturge-Weber syndrome in association with phakomatosis pigmentovascularis and Klippel-Trenaunay-Weber syndrome. Retina 2002; 22 (03) 368-371
    CrossrefPubMedGoogle Scholar
  • 72 Uysal G, Güven A, Ozhan B, Oztürk MH, Mutluay AH, Tulunay O. Phakomatosis pigmentovascularis with Sturge-Weber syndrome: a case report. J Dermatol 2000; 27 (07) 467-470
    CrossrefPubMedGoogle Scholar
  • 73 Trifiletti RR, Incorpora G, Polizzi A, Cocuzza MD, Bolan EA, Parano E. Aicardi syndrome with multiple tumors: a case report with literature review. Brain Dev 1995; 17 (04) 283-285
    CrossrefPubMedGoogle Scholar
  • 74 Polizzi A, Pavone P, Iannetti P, Manfré L, Ruggieri M. Septo-optic dysplasia complex: a heterogeneous malformation syndrome. Pediatr Neurol 2006; 34 (01) 66-71
    CrossrefPubMedGoogle Scholar
  • 75 Iannetti P, Parisi P, Spalice A, Ruggieri M, Zara F. Addition of verapamil in the treatment of severe myoclonic epilepsy in infancy. Epilepsy Res 2009; 85 (01) 89-95
    CrossrefPubMedGoogle Scholar
  • 76 Polizzi A, Coghill S, McShane MA, Squier W. Acute ataxia complicating Langherans cell histiocytosis. Arch Dis Child 2002; 86 (02) 130-131
    CrossrefPubMedGoogle Scholar
  • 77 Brancati F, Travaglini L, Zablocka D. , et al; International JSRD Study Group. RPGRIP1L mutations are mainly associated with the cerebello-renal phenotype of Joubert syndrome-related disorders. Clin Genet 2008; 74 (02) 164-170
    CrossrefPubMedGoogle Scholar
  • 78 Ruggieri M, McShane MA. Parental view of epilepsy in Angelman syndrome: a questionnaire study. Arch Dis Child 1998; 79 (05) 423-426
    CrossrefPubMedGoogle Scholar
  • 79 Ruggieri M, Polizzi A. Segmental neurofibromatosis. J Neurosurg 2000; 93 (03) 530-532
    Google Scholar
  • 80 Ruggieri M, Tigano G, Mazzone D, Tiné A, Pavone L. Involvement of the white matter in hypomelanosis of Ito (incontinentia pigmenti achromiens). Neurology 1996; 46 (02) 485-492
    CrossrefPubMedGoogle Scholar
  • 81 Ruggieri M, Polizzi A, Pavone L, Musumeci S. Thalamic syndrome in children with measles infection and selective, reversible thalamic involvement. Pediatrics 1998; 101 (1 Pt 1): 112-119
    CrossrefPubMedGoogle Scholar
  • 82 Ruggieri M. Mosaic (segmental) neurofibromatosis type 1 (NF1) and type 2 (NF2): no longer neurofibromatosis type 5 (NF5). Am J Med Genet 2001; 101 (02) 178-180
    CrossrefPubMedGoogle Scholar
  • 83 O'Connor KC, Lopez-Amaya C, Gagne D. , et al. Anti-myelin antibodies modulate clinical expression of childhood multiple sclerosis. J Neuroimmunol 2010; 223 (1-2): 92-99
    CrossrefPubMedGoogle Scholar
  • 84 Salpietro V, Polizzi A, Di Rosa G. , et al. Adrenal disorders and the paediatric brain: pathophysiological considerations and clinical implications. Int J Endocrinol 2014; 2014: 282489
    CrossrefPubMedGoogle Scholar
  • 85 Lionetti E, Francavilla R, Maiuri L. , et al. Headache in pediatric patients with celiac disease and its prevalence as a diagnostic clue. J Pediatr Gastroenterol Nutr 2009; 49 (02) 202-207
    CrossrefPubMedGoogle Scholar
  • 86 Matricardi S, Spalice A, Salpietro V. , et al. Epilepsy in the setting of full trisomy 18: a multicenter study on 18 affected children with and without structural brain abnormalities. Am J Med Genet C Semin Med Genet 2016; 172 (03) 288-295
    CrossrefPubMedGoogle Scholar
  • 87 Ruggieri M, Gabriele AL, Polizzi A. , et al. Natural history of neurofibromatosis type 2 with onset before the age of 1 year. Neurogenetics 2013; 14 (02) 89-98
    CrossrefPubMedGoogle Scholar
  • 88 Ruggieri M, Polizzi A, Spalice A. , et al. The natural history of spinal neurofibromatosis: a critical review of clinical and genetic features. Clin Genet 2015; 87 (05) 401-410
    CrossrefPubMedGoogle Scholar
  • 89 Ruggieri M, Praticò AD, Evans DGE. Diagnosis, management and new therapeutic options in childhood neurofibromatosis type 2 and related disorders. Semin Pediatr Neurol 2015; 22 (04) 240-258
    CrossrefPubMedGoogle Scholar
  • 90 Ruggieri M, Praticò AD, Serra A. , et al. Childhood neurofibromatosis type 2 (NF2) and related disorders: from bench to bedside and biologically targeted therapies. Acta Otorhinolaryngol Ital 2016; 36 (05) 345-367
    PubMedGoogle Scholar
  • 91 Caltabiano R, Magro G, Polizzi A. , et al. A mosaic pattern of INI1/SMARCB1 protein expression distinguishes schwannomatosis and NF2-associated peripheral schwannomas from solitary peripheral schwannomas and NF2-associated vestibular schwannomas. Childs Nerv Syst 2017; 33 (06) 933-940
    CrossrefPubMedGoogle Scholar
  • 92 Ruggieri M, Iannetti P, Clementi M. , et al. Neurofibromatosis type 1 and infantile spasms. Childs Nerv Syst 2009; 25 (02) 211-216
    CrossrefPubMedGoogle Scholar
  • 93 Salpietro V, Polizzi A, Bertè LF. , et al. Idiopathic intracranial hypertension: a unifying neuroendocrine hypothesis through the adrenal-brain axis. Neuroendocrinol Lett 2012; 33 (06) 569-573
    Google Scholar
  • 94 Salpietro V, Mankad K, Kinali M. , et al. Pediatric idiopathic intracranial hypertension and the underlying endocrine-metabolic dysfunction: a pilot study. J Pediatr Endocrinol Metab 2014; 27 (1-2): 107-115
    PubMedGoogle Scholar
  • 95 Ruggieri M, Pavone V, De Luca D, Franzò A, Tiné A, Pavone L. Congenital bone malformations in patients with neurofibromatosis type 1 (Nf1). J Pediatr Orthop 1999; 19 (03) 301-305
    PubMedGoogle Scholar
  • 96 Distefano G, Praticò AD. Actualities on molecular pathogenesis and repairing processes of cerebral damage in perinatal hypoxic-ischemic encephalopathy. Ital J Pediatr 2010; 36: 63
    CrossrefPubMedGoogle Scholar
  • 97 Pavone P, Rizzo R, Conti I. , et al. Primary headaches in children: clinical findings on the association with other conditions. Int J Immunopathol Pharmacol 2012; 25 (04) 1083-1091
    CrossrefPubMedGoogle Scholar
  • 98 Praticò AD, Falsaperla R, Ruggieri M, Corsello G, Pavone P. Prognostic challenges of SCN1A genetic mutations: report on two children with mild features. J Pediatr Neurol 2016; 14: 82-88
    Article in Thieme ConnectPubMedGoogle Scholar
  • 99 Polizzi A, Pavone P, Parano E, Incorpora G, Ruggieri M. Lack of progression of brain atrophy in Aicardi-Goutières syndrome. Pediatr Neurol 2001; 24 (04) 300-302
    CrossrefPubMedGoogle Scholar
  • 100 Pavone P, Briuglia S, Falsaperla R. , et al. Wide spectrum of congenital anomalies including choanal atresia, malformed extremities, and brain and spinal malformations in a girl with a de novo 5.6-Mb deletion of 13q12.11-13q12.13. Am J Med Genet A 2014; 164A (07) 1734-1743
    PubMedGoogle Scholar
  • 101 Di Landro A, Tadini GL, Marchesi L, Cainelli T. Phakomatosis pigmentovascularis: a new case with renal angiomas and some considerations about the classification. Pediatr Dermatol 1999; 16 (01) 25-30
    CrossrefPubMedGoogle Scholar
  • 102 Huang C, Lee P. Phakomatosis pigmentovascularis IIb with renal anomaly. Clin Exp Dermatol 2000; 25 (01) 51-54
    CrossrefPubMedGoogle Scholar
  • 103 Park JG, Roh KY, Lee HJ. , et al. Phakomatosis pigmentovascularis IIb with hypoplasia of the inferior vena cava and the right iliac and femoral veins causing recalcitrant stasis leg ulcers. J Am Acad Dermatol 2003; 49 (2, Suppl Case Reports): S167-S169
    CrossrefPubMedGoogle Scholar
  • 104 Diociaiuti A, Guidi B, Aguilar Sanchez JA, Feliciani C, Capizzi R, Amerio P. Phakomatosis pigmentovascularis type IIIb: a case associated with Sturge-Weber and Klippel-Trenaunay syndromes. J Am Acad Dermatol 2005; 53 (03) 536-539
    PubMedGoogle Scholar
  • 105 Ruggieri M. Familial hypomelanosis of Ito: implications for genetic counselling. Am J Med Genet 2000; 95 (01) 82-84
    CrossrefPubMedGoogle Scholar
  • 106 Ruggieri M, Magro G, Ruggieri M, Polizzi A. Tumors and hypomelanosis of Ito. Arch Pathol Lab Med 2001; 125 (05) 599-601
    PubMedGoogle Scholar
  • 107 Ruggieri M, Mastrangelo M, Spalice A. , et al. Bilateral (opercular and paracentral lobular) polymicrogyria and neurofibromatosis type 1. Am J Med Genet 2011; 155: 582-585
    CrossrefPubMedGoogle Scholar
  • 108 Pavone P, Praticò AD, Ruggieri M, Falsaperla R. Hypomelanosis of Ito: a round on the frequency and type of epileptic complications. Neurol Sci 2015; 36 (07) 1173-1180
    CrossrefPubMedGoogle Scholar
  • 109 Ruggieri M, Iannetti P, Pavone L. Delineation of a newly recognized neurocutaneous malformation syndrome with “cutis tricolor.”. Am J Med Genet A 2003; 120A (01) 110-116
    CrossrefPubMedGoogle Scholar
  • 110 Ruggieri M, Iannetti F, Polizzi A. , et al. Cataracts in the setting of a newly recognised neurocutaneous malformation syndrome with cutis tricolor. Br J Ophthalmol 2009; 93: 175-176
    PubMedGoogle Scholar
  • 111 Ruggieri M, Roggini M, Kennerknecht I, Polizzi A, Distefano A, Pavone V. Spectrum of skeletal abnormalities in a complex malformation syndrome with “cutis tricolor” (Ruggieri-Happle syndrome). Acta Paediatr 2011; 100 (01) 121-127
    CrossrefPubMedGoogle Scholar
  • 112 Nicita F, Spalice A, Roggini M. , et al. Complex malformation (Ruggieri-Happle) phenotype with “cutis tricolor” in a 10-year-old girl. Brain Dev 2012; 34 (10) 869-872
    CrossrefPubMedGoogle Scholar
  • 113 Ruggieri M, Polizzi A, Schepis C. , et al. Cutis tricolor: a literature review and report of five new cases. Quant Imaging Med Surg 2016; 6 (05) 525-534
    CrossrefPubMedGoogle Scholar
  • 114 Lionetti E, Pavone P, Kennerknecht I. , et al. Neurological manifestations in individuals with pure cutaneous or syndromic (Ruggieri-Happle syndrome) phenotypes with “cutis tricolor”: a study of 14 cases. Neuropediatrics 2010; 41 (02) 60-65
    Article in Thieme ConnectPubMedGoogle Scholar
  • 115 Happle R. Capillary malformations: a classification using specific names for specific skin disorders. J Eur Acad Dermatol Venereol 2015; 29 (12) 2295-2305
    CrossrefPubMedGoogle Scholar
  • 116 Ruggieri M, Praticò AD. Mosaic neurocutaneous disorders and their causes. Semin Pediatr Neurol 2015; 22 (04) 207-233
    CrossrefPubMedGoogle Scholar
  • 117 Shirley MD, Tang H, Gallione CJ. , et al. Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ. N Engl J Med 2013; 368 (21) 1971-1979
    CrossrefPubMedGoogle Scholar
  • 118 Kurek KC, Luks VL, Ayturk UM. , et al. Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome. Am J Hum Genet 2012; 90 (06) 1108-1115
    CrossrefPubMedGoogle Scholar
  • 119 Revencu N, Boon LM, Dompmartin A. , et al. Germline mutations in RASA1 are not found in patients with Klippel-Trenaunay Syndrome or capillary malformation with limb overgrowth. Mol Syndromol 2013; 4 (04) 173-178
    CrossrefPubMedGoogle Scholar
  • 120 Luks VL, Kamitaki N, Vivero MP. , et al. Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA. J Pediatr 2015; 166 (04) 1048-54.e1 , 5
    CrossrefPubMedGoogle Scholar
  • 121 Vahidnezhad H, Youssefian L, Uitto J. Klippel-Trenaunay syndrome belongs to the PIK3CA-related overgrowth spectrum (PROS). Exp Dermatol 2016; 25 (01) 17-19
    CrossrefPubMedGoogle Scholar
  • 122 Carvalho CH, Batista LM, Bornemann A, Acioly MA, Tatagiba M. Skull base tumor in a patient with phacomatosis pigmentovascularis. Brain Pathol 2011; 21 (06) 705-708
    CrossrefPubMedGoogle Scholar
  • 123 Lee CW, Choi DY, Oh YG, Yoon HS, Kim JD. An infantile case of Sturge-Weber syndrome in association with Klippel-Trenaunay-Weber syndrome and phakomatosis pigmentovascularis. J Korean Med Sci 2005; 20 (06) 1082-1084
    CrossrefPubMedGoogle Scholar
  • 124 Happle R. Understanding nevi, nevoid skin disorders, and cutaneous neoplasia. In: Mosaicism in Human Skin. Berlin: Springer-Verlag; 2014: 183-219
    CrossrefGoogle Scholar